Navigation Links
Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
Date:4/26/2013

that regulate normal emotional expression, they can lead to uncontrollable, disruptive episodes of crying or laughing.

"PBA causes substantial medical and social burden," said Professor Kevin Talbot , director of the Oxford Motor Neuron Disease Care & Research Center. "Appropriate management of this debilitating condition can have meaningful clinical benefits for patients. Once available in Europe, NUEDEXTA will offer an important therapeutic option to effectively manage PBA."

The European Commission, which has the authority to approve medicines for use in the European Union, generally follows the recommendations of the CHMP and typically renders a final decision within three months of the CHMP opinion. If the CHMP recommendation is formally adopted by the European Commission, NUEDEXTA would be approved for marketing in all 27 member states of the European Union plus Iceland and Norway.

For further details about the CHMP opinion, please visit the EMA website.

About NUEDEXTA
NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide, the ingredient active in the central nervous system, and quinidine sulfate, a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is approved in the U.S. for the treatment of PBA in the 20/10 mg dose strength.

NUEDEXTA Important Safety Information
NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes ty
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
2. AVANIR Pharmaceuticals To paticipate in two conferences in March
3. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
4. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
5. Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
6. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
7. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
8. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
9. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
10. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
11. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- Cynosure, Inc. (Nasdaq: CYNO ... treatment systems for high-volume applications, today reported financial results ... 2014 financial results incorporate the acquisition of Palomar Medical ... Second-Quarter 2014 Financial Highlights ... , Non-GAAP net income of $7.1 million, or ...
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)... , July 29, 2014  Drug development for ... rising incidence rates and the intense need for ... vaccine. Change is underway as the market moves ... highly effective, easily-tolerated, interferon-free oral therapies. ... Gilead,s mega blockbuster Sovaldi is the first ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of 16,300,000 shares of ... per share to the public. The gross proceeds to ... $130,400,000, before deducting underwriting discounts and commissions, and other ...
... 26, 2011 American Scientific Resources, Inc. (OTCQB: ASFX) ... and Sanomedics International Holdings, Inc., and its affiliates, have ... United States District Court for the Southern District of ... judge, Hon. Ursula Ungaro, and the case has been ...
Cached Medicine Technology:Rigel Announces Pricing of Public Offering of Common Stock 2Rigel Announces Pricing of Public Offering of Common Stock 3American Scientific Resources, Inc. Announces Dismissal of Sanomedics International Holdings, Inc. lawsuit 2
(Date:7/30/2014)... 30, 2014 Pain Free Living web: ... bracelet for pain relief and improved performance. This new ... embedded in a silicone core that is sheathed in ... and is embedded with scalar energy and Schumann frequency ... Free Living has 12 years experience developing magnetic bracelets. ...
(Date:7/29/2014)... 30, 2014 Recently, iFitDress.com, a well-known wedding ... satin bridal gowns . Aside from this, it has ... up to 68 percent off. All of its old and ... The company’s sales representative says excitedly, “We are pleased to ... new range, there are a lot of amazing items. It ...
(Date:7/29/2014)... 30, 2014 VogueQueen.com, a well-known online ... the newest trends in garment fashion by providing graceful ... is selling an all-inclusive array of sexy dresses ... online, a lot of customers take price into consideration. ... That makes the purchase more affordable for all clients. ...
(Date:7/29/2014)... diet rich in soy may help feminine hearts, but ... in Menopause , the journal of The North ... the diet of women in Asia, produces the least ... to Asian migrants to North America, leads to just ... switching to soy from a Western diet after menopause ...
(Date:7/29/2014)... Daily Gossip indicates in its Natural Cure for Yeast Infection ... who is looking for an all-natural holistic cure for this ... Sarah Summer, says that her method is 100 percent natural. ... this is the reason why she was so determined in ... Natural Cure for Yeast Infection review indicates that Sarah ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:VogueQueen.com Now Provides Graceful And Sexy Lingerie Collection For August 2Health News:Soy may help women's hearts if they start early 2Health News:Natural Cure for Yeast Infection Review Reveals Sarah Summer’s Healing Method 2
... , VIRGINIA BEACH, Va., Jan. 11, 2010 Amerigroup ... report its earnings for the fourth quarter and the fiscal year ... Friday, February 19, 2010. At 8:30 a.m. Eastern Time on ... webcast to discuss earnings and other information. , To listen to ...
... , KNOXVILLE, Tenn., Jan. 11 TeamHealth ... that the underwriters of its recent initial public offering of ... an additional 1,995,000 shares of common stock from the Company ... intends to use the additional net proceeds of approximately $22.5 ...
... Jan. 11 The California Dental Association (CDA) ... charitable Dental Student Loan Repayment Grant Program. Two California ... each receive a maximum of $105,000 to help offset ... commitment to work in an underserved community. , ...
... to be part of the ,culture, at some centers, one ... Americans in nursing homes still get powerful antipsychotic medications, despite ... practice, two new studies show. , The practice can control ... U.S. Food and Drug Administration instituted a "black box" warning ...
... ... Corpus Christi and Austin, Texas areas. , ... San Antonio, TX (PRWEB) January 11, 2010 -- Physicians Health ... choices and benefits than original Medicare -- is pleased to announce it is partnering ...
... , SC AG McMaster to ... , WASHINGTON, Jan. 11 South Carolina Attorney ... general into the constitutionality of the health care reform bill ... press conference at 2:00 p.m. on Wednesday, January 13th, ...
Cached Medicine News:Health News:Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19 2Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 2Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 3Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 4Health News:California Dental Association Foundation Awards More Than $200,000 in Community Service Grants 2Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 2Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 3Health News:Top-Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 2Health News:Top-Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 3
... The new Guidant VASOVIEW® HemoPro™ ... deliver a new level of ... for both the saphenous vein ... cut-and-seal capability, it lets you ...
Patient Monitor...
...
... or antepartum GBS results can be available in ... revolutionary in vitro diagnostic test is the first ... in the clinical lab and near-patient by non-laboratory ... 24 hours a day, 365 days a year. ...
Medicine Products: